STOCK TITAN

[8-K] Semler Scientific, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Semler Scientific (Nasdaq:SMLR) filed a Form 8-K to report that on June 22, 2025 its board adopted Fifth Amended and Restated Bylaws, effective immediately.

According to Item 5.03, the revisions are limited to two governance housekeeping items: (i) removal of Section 13 to eliminate any ambiguity with Delaware General Corporation Law §228 (shareholder written consents) and (ii) revision of Section 47 so that the bylaws fully harmonize with the company’s certificate of incorporation. No changes were made to the fiscal year, capital structure, or shareholder voting thresholds.

The full text of the updated bylaws is provided as Exhibit 3.1. Other than the technical governance clean-up, the filing contains no financial statements, forward-looking guidance, or other material events. The document was signed by Chief Financial Officer Renae Cormier on June 23, 2025.

Semler Scientific (Nasdaq:SMLR) ha presentato un modulo 8-K per comunicare che il 22 giugno 2025 il suo consiglio di amministrazione ha adottato il Quinto Statuto Modificato e Riformulato, con effetto immediato.

Secondo il Punto 5.03, le modifiche riguardano esclusivamente due aspetti di gestione interna: (i) rimozione della Sezione 13 per eliminare qualsiasi ambiguità con la Delaware General Corporation Law §228 (consensi scritti degli azionisti) e (ii) revisione della Sezione 47 affinché lo statuto sia completamente allineato con il certificato di incorporazione della società. Non sono state apportate modifiche all’anno fiscale, alla struttura del capitale o alle soglie di voto degli azionisti.

Il testo completo del nuovo statuto è disponibile come Allegato 3.1. A parte questa pulizia tecnica della governance, il documento non contiene bilanci finanziari, previsioni future o altri eventi rilevanti. Il documento è stato firmato dal Direttore Finanziario Renae Cormier il 23 giugno 2025.

Semler Scientific (Nasdaq:SMLR) presentó un Formulario 8-K para informar que el 22 de junio de 2025 su junta directiva adoptó los Estatutos Reformados y Enmendados Quinta Versión, con efecto inmediato.

Según el Punto 5.03, las revisiones se limitan a dos aspectos administrativos de gobernanza: (i) eliminación de la Sección 13 para eliminar cualquier ambigüedad con la Delaware General Corporation Law §228 (consentimientos escritos de los accionistas) y (ii) revisión de la Sección 47 para que los estatutos armonicen completamente con el certificado de incorporación de la empresa. No se hicieron cambios en el año fiscal, la estructura de capital ni los umbrales de votación de los accionistas.

El texto completo de los estatutos actualizados se proporciona como Anexo 3.1. Aparte de esta limpieza técnica de gobernanza, la presentación no contiene estados financieros, proyecciones futuras u otros eventos materiales. El documento fue firmado por la Directora Financiera Renae Cormier el 23 de junio de 2025.

Semler Scientific (Nasdaq:SMLR)는 2025년 6월 22일 이사회가 제5차 수정 및 재작성된 정관을 즉시 발효하여 채택했다고 보고하기 위해 Form 8-K를 제출했습니다.

항목 5.03에 따르면, 수정 사항은 두 가지 거버넌스 관리 항목으로 제한됩니다: (i) 제13조 삭제델라웨어 일반 회사법 §228 (주주 서면 동의)과의 모호성을 제거하고, (ii) 제47조 수정으로 정관이 회사의 설립 증명서와 완전히 일치하도록 했습니다. 회계 연도, 자본 구조 또는 주주 투표 기준에는 변경이 없습니다.

업데이트된 정관 전체 텍스트는 첨부서류 3.1로 제공됩니다. 기술적인 거버넌스 정리 외에는 재무제표, 미래 전망 또는 기타 중요한 사건이 포함되어 있지 않습니다. 이 문서는 2025년 6월 23일 최고재무책임자 Renae Cormier가 서명했습니다.

Semler Scientific (Nasdaq:SMLR) a déposé un formulaire 8-K pour signaler que, le 22 juin 2025, son conseil d'administration a adopté les Statuts modifiés et reformulés pour la cinquième fois, avec effet immédiat.

Selon le point 5.03, les révisions se limitent à deux points administratifs de gouvernance : (i) suppression de la Section 13 afin d'éliminer toute ambiguïté avec la Delaware General Corporation Law §228 (consentements écrits des actionnaires) et (ii) révision de la Section 47 pour que les statuts soient parfaitement harmonisés avec le certificat de constitution de la société. Aucun changement n'a été apporté à l'exercice fiscal, à la structure du capital ou aux seuils de vote des actionnaires.

Le texte complet des statuts mis à jour est fourni en Annexe 3.1. En dehors de ce nettoyage technique de gouvernance, le dépôt ne contient aucun état financier, aucune prévision prospective ni aucun autre événement important. Le document a été signé par la directrice financière Renae Cormier le 23 juin 2025.

Semler Scientific (Nasdaq:SMLR) reichte ein Formular 8-K ein, um mitzuteilen, dass der Vorstand am 22. Juni 2025 die Fünfte geänderte und neu gefasste Satzung mit sofortiger Wirkung angenommen hat.

Gemäß Punkt 5.03 beschränken sich die Änderungen auf zwei verwaltungsbezogene Governance-Punkte: (i) Entfernung von Abschnitt 13, um jegliche Unklarheiten mit dem Delaware General Corporation Law §228 (schriftliche Zustimmung der Aktionäre) zu beseitigen, und (ii) Überarbeitung von Abschnitt 47, damit die Satzung vollständig mit der Satzungsurkunde des Unternehmens übereinstimmt. Es wurden keine Änderungen am Geschäftsjahr, an der Kapitalstruktur oder an den Abstimmungsschwellen der Aktionäre vorgenommen.

Der vollständige Text der aktualisierten Satzung ist als Anlage 3.1 beigefügt. Abgesehen von dieser technischen Governance-Bereinigung enthält die Einreichung keine Finanzberichte, zukunftsgerichteten Prognosen oder sonstige wesentliche Ereignisse. Das Dokument wurde am 23. Juni 2025 vom Finanzvorstand Renae Cormier unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Technical bylaw cleanup; limited immediate shareholder impact.

Removing Section 13 averts conflicts with DGCL §228, while aligning Section 47 with the charter tightens internal consistency. Because the update does not introduce anti-takeover provisions or alter voting rights, it should be viewed as prudent maintenance rather than a strategic shift. Shareholder influence and the company’s M&A defensibility remain unchanged; therefore the filing is governance-neutral and financially immaterial.

TL;DR: Bylaw revisions align with Delaware law, reducing litigation risk.

Clarifying the written-consent mechanism under DGCL §228 helps avoid procedural challenges in future corporate actions and may streamline consent solicitations. Harmonizing Section 47 removes potential discrepancies between governing documents, a step that can lower transaction costs in any future financing or M&A activity. Because no substantive rights were added or curtailed, market impact is neutral; the change is chiefly compliance-driven.

Semler Scientific (Nasdaq:SMLR) ha presentato un modulo 8-K per comunicare che il 22 giugno 2025 il suo consiglio di amministrazione ha adottato il Quinto Statuto Modificato e Riformulato, con effetto immediato.

Secondo il Punto 5.03, le modifiche riguardano esclusivamente due aspetti di gestione interna: (i) rimozione della Sezione 13 per eliminare qualsiasi ambiguità con la Delaware General Corporation Law §228 (consensi scritti degli azionisti) e (ii) revisione della Sezione 47 affinché lo statuto sia completamente allineato con il certificato di incorporazione della società. Non sono state apportate modifiche all’anno fiscale, alla struttura del capitale o alle soglie di voto degli azionisti.

Il testo completo del nuovo statuto è disponibile come Allegato 3.1. A parte questa pulizia tecnica della governance, il documento non contiene bilanci finanziari, previsioni future o altri eventi rilevanti. Il documento è stato firmato dal Direttore Finanziario Renae Cormier il 23 giugno 2025.

Semler Scientific (Nasdaq:SMLR) presentó un Formulario 8-K para informar que el 22 de junio de 2025 su junta directiva adoptó los Estatutos Reformados y Enmendados Quinta Versión, con efecto inmediato.

Según el Punto 5.03, las revisiones se limitan a dos aspectos administrativos de gobernanza: (i) eliminación de la Sección 13 para eliminar cualquier ambigüedad con la Delaware General Corporation Law §228 (consentimientos escritos de los accionistas) y (ii) revisión de la Sección 47 para que los estatutos armonicen completamente con el certificado de incorporación de la empresa. No se hicieron cambios en el año fiscal, la estructura de capital ni los umbrales de votación de los accionistas.

El texto completo de los estatutos actualizados se proporciona como Anexo 3.1. Aparte de esta limpieza técnica de gobernanza, la presentación no contiene estados financieros, proyecciones futuras u otros eventos materiales. El documento fue firmado por la Directora Financiera Renae Cormier el 23 de junio de 2025.

Semler Scientific (Nasdaq:SMLR)는 2025년 6월 22일 이사회가 제5차 수정 및 재작성된 정관을 즉시 발효하여 채택했다고 보고하기 위해 Form 8-K를 제출했습니다.

항목 5.03에 따르면, 수정 사항은 두 가지 거버넌스 관리 항목으로 제한됩니다: (i) 제13조 삭제델라웨어 일반 회사법 §228 (주주 서면 동의)과의 모호성을 제거하고, (ii) 제47조 수정으로 정관이 회사의 설립 증명서와 완전히 일치하도록 했습니다. 회계 연도, 자본 구조 또는 주주 투표 기준에는 변경이 없습니다.

업데이트된 정관 전체 텍스트는 첨부서류 3.1로 제공됩니다. 기술적인 거버넌스 정리 외에는 재무제표, 미래 전망 또는 기타 중요한 사건이 포함되어 있지 않습니다. 이 문서는 2025년 6월 23일 최고재무책임자 Renae Cormier가 서명했습니다.

Semler Scientific (Nasdaq:SMLR) a déposé un formulaire 8-K pour signaler que, le 22 juin 2025, son conseil d'administration a adopté les Statuts modifiés et reformulés pour la cinquième fois, avec effet immédiat.

Selon le point 5.03, les révisions se limitent à deux points administratifs de gouvernance : (i) suppression de la Section 13 afin d'éliminer toute ambiguïté avec la Delaware General Corporation Law §228 (consentements écrits des actionnaires) et (ii) révision de la Section 47 pour que les statuts soient parfaitement harmonisés avec le certificat de constitution de la société. Aucun changement n'a été apporté à l'exercice fiscal, à la structure du capital ou aux seuils de vote des actionnaires.

Le texte complet des statuts mis à jour est fourni en Annexe 3.1. En dehors de ce nettoyage technique de gouvernance, le dépôt ne contient aucun état financier, aucune prévision prospective ni aucun autre événement important. Le document a été signé par la directrice financière Renae Cormier le 23 juin 2025.

Semler Scientific (Nasdaq:SMLR) reichte ein Formular 8-K ein, um mitzuteilen, dass der Vorstand am 22. Juni 2025 die Fünfte geänderte und neu gefasste Satzung mit sofortiger Wirkung angenommen hat.

Gemäß Punkt 5.03 beschränken sich die Änderungen auf zwei verwaltungsbezogene Governance-Punkte: (i) Entfernung von Abschnitt 13, um jegliche Unklarheiten mit dem Delaware General Corporation Law §228 (schriftliche Zustimmung der Aktionäre) zu beseitigen, und (ii) Überarbeitung von Abschnitt 47, damit die Satzung vollständig mit der Satzungsurkunde des Unternehmens übereinstimmt. Es wurden keine Änderungen am Geschäftsjahr, an der Kapitalstruktur oder an den Abstimmungsschwellen der Aktionäre vorgenommen.

Der vollständige Text der aktualisierten Satzung ist als Anlage 3.1 beigefügt. Abgesehen von dieser technischen Governance-Bereinigung enthält die Einreichung keine Finanzberichte, zukunftsgerichteten Prognosen oder sonstige wesentliche Ereignisse. Das Dokument wurde am 23. Juni 2025 vom Finanzvorstand Renae Cormier unterzeichnet.

0001554859false--12-3100015548592025-06-222025-06-22

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 22, 2025

SEMLER SCIENTIFIC, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

001-36305

    

26-1367393

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

51 E Campbell Ave, Suite 107-D
CampbellCA

    

95008

(Address of principal executive offices)

 

(Zip Code)

Registrant’s telephone number, including area code: (877) 774-4211

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

   

Trading 
Symbol(s)

    

Name of each exchange on which registered

Common Stock, $0.001 par value per share

 

SMLR

 

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On June 22, 2025, Semler Scientific, Inc.’s board of directors approved and adopted its Fifth Amended and Restated Bylaws, or the Fifth A&R Bylaws, with immediate effect.

The Fifth A&R Bylaws were adopted to (i) remove Section 13 to avoid any ambiguity with respect to Delaware General Corporation Law 228 and (ii) revise Section 47 to harmonize with the certificate of incorporation.

The foregoing summary and description of the Fifth A&R Bylaws does not purport to be complete and is qualified in its entirety by reference to the full text of the Fifth A&R Bylaws, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No. 

Description

3.1

Fifth Amended and Restated Bylaws of Semler Scientific, Inc.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

SEMLER SCIENTIFIC, INC.

 

 

 

Date: June 23, 2025

By:

/s/ Renae Cormier

 

 

Name: Renae Cormier

Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

FAQ

Why did SMLR adopt the Fifth Amended and Restated Bylaws on June 22, 2025?

The board removed Section 13 to avoid ambiguity with Delaware DGCL §228 and revised Section 47 to align wording with the certificate of incorporation.

Did the bylaw amendments change shareholder rights to act by written consent?

No. The update clarifies the process but does not alter shareholders’ ability to act by written consent under DGCL §228.

Were any financial statements or metrics included in this 8-K?

No. The filing solely addresses bylaw amendments and contains no financial statements or performance metrics.

Which exhibit contains the full text of the updated bylaws for Semler Scientific?

The complete Fifth Amended and Restated Bylaws are filed as Exhibit 3.1 to the Form 8-K.

Who signed the Form 8-K and what is their position at SMLR?

Chief Financial Officer Renae Cormier signed the report in her capacity as Principal Financial Officer and Principal Accounting Officer.
Semler Scientific Inc

NASDAQ:SMLR

SMLR Rankings

SMLR Latest News

SMLR Latest SEC Filings

SMLR Stock Data

474.92M
9.39M
18.39%
61.37%
17.11%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
CAMPBELL